Article
Exploring lncRNAs as Biomarkers for Monitoring Hepatocellular Carcinoma Immunotherapy Response
2026-07-28
Abstract excerpt
<title>Abstract</title> <p>Hepatocellular carcinoma (HCC) is one of the deadliest malignancies globally, characterised by a mean survival of 3 to 4 months upon late-stage diagnosis. While immunotherapy has shown success in managing HCC within specific patient subgroups, overall treatment response rates remain poor worldwide. In this study, we systematically investigated the role of long non-coding RNAs (lncRNAs)...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7d9e5380-c46c-5270-9199-b2b7047044e6
- DOI
- 10.21203/rs.3.rs-10483008/v1
